- Galectin Therapeutics (NASDAQ:GALT): FY'14 EPS of -$0.70 vs. -$1.3 in FY'13
- Cash & cash equivalents of $29.12M
- Press Release
Galectin Therapeutics reports FY'14 results
Recommended For You
About GALT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| GALT | - | - |
| Galectin Therapeutics Inc. | ||